Our findings provide robust real‐world evidence that short bouts of PA, when used alongside insulin therapy, can rapidly lower glucose by ~2.0 mmol/L within 20 min, without increasing immediate hypoglycaemia risk. This evidence concerns the gene INS and Hypoglycemia.